TW251288B - - Google Patents

Info

Publication number
TW251288B
TW251288B TW81104508A TW81104508A TW251288B TW 251288 B TW251288 B TW 251288B TW 81104508 A TW81104508 A TW 81104508A TW 81104508 A TW81104508 A TW 81104508A TW 251288 B TW251288 B TW 251288B
Authority
TW
Taiwan
Application number
TW81104508A
Other languages
Chinese (zh)
Original Assignee
Takeda Dharm Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Dharm Industry Co Ltd filed Critical Takeda Dharm Industry Co Ltd
Application granted granted Critical
Publication of TW251288B publication Critical patent/TW251288B/zh

Links

TW81104508A 1991-06-27 1992-06-10 TW251288B (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP15719491 1991-06-27
JP18888291 1991-07-29
JP19205491 1991-07-31
JP28821791 1991-08-12
JP23976491 1991-09-19

Publications (1)

Publication Number Publication Date
TW251288B true TW251288B (pt) 1995-07-11

Family

ID=27528143

Family Applications (1)

Application Number Title Priority Date Filing Date
TW81104508A TW251288B (pt) 1991-06-27 1992-06-10

Country Status (2)

Country Link
CN (1) CN1040755C (pt)
TW (1) TW251288B (pt)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI447114B (zh) * 2011-09-30 2014-08-01 Sunshine Lake Pharma Co Ltd 阿齊沙坦的新晶型及其製備方法

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101151260B (zh) * 2005-03-30 2011-06-29 武田药品工业株式会社 苯并咪唑衍生物及其作为血管紧张素ⅱ拮抗剂的用途
NZ594606A (en) * 2009-01-30 2013-06-28 Takeda Pharmaceutical Fused ring compound and use thereof
RU2554947C2 (ru) * 2009-11-30 2015-07-10 Цзянсу Хансох Фармасьютикал Груп Ко., Лтд. Соли азилсартана с органическими аминами, способ их получения и применение
CZ306650B6 (cs) * 2011-03-04 2017-04-19 Zentiva, K.S. Způsob výroby 2-ethoxy-1-((2´-((hydroxyamino)iminomethyl)bifenyl-4-yl)methyl)-1H-benzo[d]imidazol-7-karboxylové kyseliny a jejích esterů, klíčových intermediátů syntézy azilsartanu
CN102827153B (zh) * 2011-06-14 2016-10-05 江苏豪森药业集团有限公司 阿齐沙坦的晶型及其制备方法
CN102731491B (zh) * 2012-07-04 2015-03-18 北京科莱博医药开发有限责任公司 一种阿齐沙坦中间体的制备方法
CN102731408A (zh) * 2012-07-20 2012-10-17 江苏先声药物研究有限公司 一种阿齐沙坦中间体及其制备方法
CN102766139B (zh) * 2012-08-14 2014-09-17 江苏先声药物研究有限公司 阿齐沙坦的多晶型物及其制备方法
CN103113364B (zh) * 2012-08-27 2015-11-18 南京华威医药科技开发有限公司 阿齐沙坦多晶型的制备方法
CN103664920B (zh) * 2012-09-24 2016-03-09 上海医药工业研究院 阿奇沙坦中间体及其与阿奇沙坦的制备方法
CN103880830B (zh) * 2013-03-22 2017-01-18 江西同和药业股份有限公司 一种阿齐沙坦的合成方法
CN104072490A (zh) * 2013-03-28 2014-10-01 江苏柯菲平医药有限公司 一种阿奇沙坦关键中间体的制备方法
CN104119326B (zh) * 2013-04-25 2017-04-26 正大天晴药业集团股份有限公司 一种阿齐沙坦的制备方法
CN103242305B (zh) * 2013-05-11 2018-02-27 迪沙药业集团有限公司 一种阿齐沙坦的制备方法
CN103372017A (zh) * 2013-07-04 2013-10-30 丁圣雨 Chukrasone A在制备治疗动脉粥样硬化药物中的应用
CN103408500B (zh) * 2013-07-25 2016-03-16 上海博志研新药物技术有限公司 一种血管紧张素ⅱ受体拮抗剂及其关键中间体的制备方法
CN104418807A (zh) * 2013-09-09 2015-03-18 天津药物研究院 一种2-乙氧基-1-[[2`-(羟基脒基)-联苯基]-4-基]甲基-1h-苯并咪唑-7-羧酸及其酯衍生物的制备方法
CN106032378B (zh) * 2015-03-20 2019-10-25 武汉启瑞药业有限公司 新型arb化合物及其用途
CN106478515B (zh) * 2016-10-13 2018-11-23 艾美科健（中国）生物医药有限公司 一种阿齐沙坦中间体的制备方法
CN110194749B (zh) * 2019-07-08 2022-04-26 福州大学 3-三氟(二氟)甲基-1,2,4-三氮唑-5-酮类化合物的合成方法
CN112745302A (zh) * 2019-10-31 2021-05-04 上海中医药大学附属龙华医院 苯并咪唑类化合物及其医药用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4508718A (en) * 1984-01-16 1985-04-02 Warner-Lambert Company Cardiotonic and antihypertensive oxadiazinone compounds
EP0400835A1 (en) * 1989-05-15 1990-12-05 Merck & Co. Inc. Substituted benzimidazoles as angiotensin II antagonists
CA2020073A1 (en) * 1989-07-03 1991-01-04 Eric E. Allen Substituted quinazolinones as angiotensin ii antagonists

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI447114B (zh) * 2011-09-30 2014-08-01 Sunshine Lake Pharma Co Ltd 阿齊沙坦的新晶型及其製備方法
US9174973B2 (en) 2011-09-30 2015-11-03 Sunshine Lake Pharma Co., Ltd. Crystalline forms of azilsartan and preparation and uses thereof

Also Published As

Publication number Publication date
CN1040755C (zh) 1998-11-18
CN1067890A (zh) 1993-01-13

Similar Documents

Publication Publication Date Title
TW229230B (pt)
DK0616505T3 (pt)
DK0578681T3 (pt)
EP0530988A3 (pt)
EP0512225A3 (pt)
TW251288B (pt)
DE4291684T1 (pt)
FR2672423B1 (pt)
EP0503606A3 (pt)
FR2674074B1 (pt)
FR2671520B1 (pt)
DE4290056T1 (pt)
EP0501430A3 (pt)
DE4292012T1 (pt)
ECSM91533U (pt)
ECSM91545U (pt)
EP0541226A3 (pt)
EP0512826A3 (pt)
EP0509424A3 (pt)
EP0508059A3 (pt)
EP0507384A3 (pt)
EP0511606A3 (pt)
EP0502497A3 (pt)
EP0572674A4 (pt)
AU8476191A (pt)